Walleye Trading LLC Exelixis, Inc. Transaction History

Walleye Trading LLC

$46 Billion
Q4 2024

A detailed history of Walleye Trading LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 2,520 shares of EXEL stock, worth $88,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,520

Previous 74,100 96.6%

Holding current value

$88,200

Previous $1.92 Million 95.68%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$25.39 - $36.46 $63,982 - $91,879	2,520 New	2,520 $83,000
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $212,828 - $266,781	-11,056 Reduced 12.59%	76,743 $1.84 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $1.38 Million - $1.65 Million	72,510 Added 474.26%	87,799 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $277,801 - $313,118	15,289 New	15,289 $292,000
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $145,212 - $206,242	-9,261 Reduced 20.49%	35,947 $564,000
Q2 2022 Aug 08, 2022	BUY	$17.44 - $23.16 $614,062 - $815,463	35,210 Added 352.17%	45,208 $941,000
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $203,883 - $271,405	-11,972 Reduced 54.49%	9,998 $227,000
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $167,412 - $231,249	10,569 Added 92.7%	21,970 $402,000
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $31,915 - $45,445	-1,778 Reduced 13.49%	11,401 $208,000
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $11,024 - $13,543	537 Added 4.25%	13,179 $298,000
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $232,486 - $313,521	12,642 New	12,642 $254,000
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $109,245 - $181,986	-6,637 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $104,835 - $158,050	-7,250 Reduced 52.21%	6,637 $114,000
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $218,224 - $279,568	12,343 Added 799.42%	13,887 $246,000
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $8,244 - $13,167	-604 Reduced 28.12%	1,544 $30,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $440,558 - $532,895	-23,737 Reduced 91.7%	2,148 $46,000
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $627,193 - $800,623	25,885 New	25,885 $787,000
Q3 2017 Nov 14, 2017	SELL	$23.35 - $29.24 $397,066 - $497,226	-17,005 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	17,005	17,005 $419,000

Others Institutions Holding EXEL

# of Institutions

569

Shares Held

249M

Call Options Held

1.72M

Put Options Held

1.54M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account

Walleye Trading LLC Exelixis, Inc. Transaction History